Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2015 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Abstracts Accepted for Presentation at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology

LEXINGTON, Mass., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
February 02, 2015 01:41 ET | Source: NICOX

Nicox signs exclusive license agreement with InSite Vision for AzaSite(R) and BromSite(TM) in Europe

InSite grants Nicox exclusive license for AzaSite® (1% azithromycin), BromSite(TM) (0.075% bromfenac) and AzaSite Xtra(TM) (2% azithromycin) in Europe, Middle East and Africa European...
February 02, 2015 01:30 ET | Source: NICOX SA

Nicox signe un accord de licence exclusif avec InSite Vision pour AzaSite® et BromSite(TM) en Europe

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Nicox signe un accord de licence...
February 02, 2015 01:30 ET | Source: NICOX SA

Nicox signs exclusive license agreement with InSite Vision for AzaSite® and BromSite(TM) in Europe

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Nicox signs exclusive license agreement...
February 02, 2015 01:15 ET | Source: Novartis Pharma AG

Alcon receives FDA approval of Pazeo(TM) Solution for ocular allergy itch relief

US Food and Drug Administration grants approval of Pazeo(TM) (olopatadine hydrochloride ophthalmic solution) 0.7% for sale in the United States Developed with efficacy data at 24 hours, post...
January 29, 2015 10:00 ET | Source: Lumenis Ltd.

Lumenis Announces Fourth Quarter and Fiscal Year 2014 Earnings Conference Call

YOKNEAM, Israel, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (Nasdaq:LMNS), the world's largest medical laser company for surgical, ophthalmology and aesthetic applications, today announced plans...
January 29, 2015 07:07 ET | Source: Gulfcoast Eye Care

Glaucoma Awareness Month -- Tampa Bay Eye Doctor Discusses the "Silent Thief" of Sight

TAMPA BAY, FL--(Marketwired - Jan 29, 2015) - January is Glaucoma Awareness Month, and one Tampa Bay ophthalmologist is spreading the word about how individuals can protect themselves from the...
January 29, 2015 07:00 ET | Source: Beacon Therapeutics (USA), Inc.

AGTC Appoints Stephen W. Potter Chief Business Officer

GAINESVILLE, Fla., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
January 29, 2015 04:00 ET | Source: Lumenis Ltd.

Lumenis Further Expands Its Product Line With a New ResurFX(TM)* System - A True Fractional Non-Ablative Stand-Alone Skin Resurfacing Solution

YOKNEAM, Israel, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (Nasdaq:LMNS), the world's largest energy-based medical company for aesthetic, surgical and ophthalmology applications, announced today...
January 28, 2015 07:00 ET | Source: RestorGenex

RestorGenex Granted Orphan Drug Designation for RES-529 for Treatment of Glioblastoma Multiforme

BUFFALO GROVE, Ill., Jan. 28, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...